Fordyce Marshallinsider trades
In SEC Form 4 filings, Fordyce Marshall is listed as PRESIDENT AND CEO of Vera Therapeutics, Inc. (VERA). In the last 90 days, Fordyce Marshall sold $1.33M of Vera Therapeutics, Inc. (VERA) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| VERAVera Therapeutics, Inc. | PRESIDENT AND CEO | 6 | Sep 17 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-04
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| VERAVera Therapeutics, Inc. | Sep 15 | Sep 17 | M | 18,500 | $2.90 | $53,591 | 253,744 | Yes | Form 4 |
| VERAVera Therapeutics, Inc. | Sep 15 | Sep 17 | S | 18,500 | $37.00 | Sale −$684,500 | 235,244 | Yes | Form 4 |
| VERAVera Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 18,500 | $2.90 | $53,591 | 488,801 | Yes | Form 4 |
| VERAVera Therapeutics, Inc. | Sep 2 | Sep 4 | M | 18,500 | $2.90 | $53,591 | 253,744 | Yes | Form 4 |
| VERAVera Therapeutics, Inc. | Sep 2 | Sep 4 | S | 18,500 | $35.12 | Sale −$649,642 | 235,244 | Yes | Form 4 |
| VERAVera Therapeutics, Inc. | Sep 2 | Sep 4 | M · derivative | 18,500 | $2.90 | $53,591 | 507,301 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.